This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine | |
|---|---|
| Name | Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine |
| Formation | 1990s |
| Type | Professional association |
| Headquarters | Sydney, Australia |
| Region served | Australia and New Zealand |
| Leader title | President |
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine is a professional association representing clinicians and researchers in HIV, viral hepatitis and sexual health across Australia and New Zealand. The society engages with hospitals, universities, and public health agencies to develop clinical standards and influence policy for infectious diseases and sexual health services. It collaborates with international bodies and national organisations to advance care, training and research in Australasia.
The organisation emerged during the 1990s amid responses to the AIDS epidemic, interaction with the World Health Organization, and developments in antiretroviral therapy following breakthroughs associated with Truvada and protease inhibitor research linked to teams at Massachusetts General Hospital, University of California, San Francisco, and Imperial College London. Early membership drew clinicians from institutions such as Royal Prince Alfred Hospital, St Vincent's Hospital, Sydney, and research units affiliated with the University of Sydney and the University of Melbourne. The society’s evolution paralleled policy shifts influenced by reports from bodies like the Kirby Review and collaborations with agencies including Pharmaceutical Benefits Advisory Committee and the New Zealand Ministry of Health. Over time it developed formal links with regional groups such as the Australian Society for Infectious Diseases and international organisations including the International AIDS Society and the European AIDS Clinical Society.
The society’s mission emphasises improving patient outcomes in HIV and viral hepatitis through evidence-based clinical care, education and advocacy, aligning with priorities from the United Nations Sustainable Development agenda and targets set by programs like UNAIDS and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Objectives include producing clinical guidance similar to initiatives by the Centers for Disease Control and Prevention, fostering workforce capacity akin to training in the Royal Australasian College of Physicians, and influencing health policy alongside entities such as Australian Department of Health and Aged Care and New Zealand AIDS Foundation.
Membership comprises clinicians, researchers and trainees from hospitals and universities including Monash University, University of Queensland, University of Otago, and specialist services at Prince Henry Hospital and Greenlane Clinical Centre. Governance follows a board structure with elected officers, committees and subcommittees that mirror governance models used by the Royal College of General Practitioners, the Australasian College for Emergency Medicine, and the Australian Medical Association. The society engages with allied organisations such as the Public Health Association of Australia and the Australian Federation of AIDS Organisations on stakeholder representation and ethics oversight comparable to frameworks used by the National Health and Medical Research Council.
The society provides accredited education, training modules and continuing professional development similar to programs offered by the Royal Australian College of General Practitioners and the Royal Australasian College of Surgeons. It runs mentorship and fellowship opportunities linked to hospitals like Westmead Hospital and university departments at Deakin University and Griffith University. Training addresses clinical competencies reflected in curricula from the Faculty of Infectious Diseases and aligns with international training standards promoted by the British HIV Association and the Infectious Diseases Society of America.
The society issues clinical guidelines and position statements on antiretroviral therapy, viral hepatitis treatment and sexual health screening that intersect with directives from the Therapeutic Goods Administration and reimbursement rules influenced by the Pharmaceutical Benefits Scheme. Its policy submissions have been directed to legislative and advisory bodies including the Australian Senate committees, the New Zealand Parliament health select committees, and regulatory reviews such as those undertaken by the Australian Law Reform Commission on public health legislation. Guideline development incorporates evidence and consensus processes comparable to methods used by the National Institute for Health and Care Excellence and the Cochrane Collaboration.
Members contribute to clinical trials, cohort studies and observational research affiliated with research institutes such as the Kirby Institute, the Peter Doherty Institute for Infection and Immunity, and the Burnet Institute. Publications appear in journals like the Medical Journal of Australia, The Lancet HIV, and Clinical Infectious Diseases, and the society disseminates technical resources, white papers and consensus statements similar to outputs from the Australian Government Department of Health research units. Collaborative research spans partnerships with organisations including the Australian Research Council, the National Institutes of Health, and philanthropic funders such as the Bill & Melinda Gates Foundation.
Annual scientific meetings and symposia draw delegates from across Australasia and internationally, with keynote speakers from institutions such as Harvard Medical School, Johns Hopkins University, University College London and invited experts from the European Centre for Disease Prevention and Control. Events incorporate workshops, poster sessions and clinical masterclasses hosted at venues in Melbourne, Sydney and Auckland, and frequently partner with societies like the International Congress on AIDS in Asia and the Pacific and the Asia-Pacific HIV Conference. The society also organises satellite meetings with agencies including the World Health Organization South-East Asia Regional Office and the Pacific Community.
Category:Medical associations in Australia Category:Medical associations in New Zealand Category:HIV/AIDS organizations